OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ingestion-time differences in the pharmacodynamics of hypertension medications: Systematic review of human chronopharmacology trials
Ramón C. Hermida, Ramon G. Hermida‐Ayala, Michael H. Smolensky, et al.
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 200-213
Open Access | Times Cited: 25
Ramón C. Hermida, Ramon G. Hermida‐Ayala, Michael H. Smolensky, et al.
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 200-213
Open Access | Times Cited: 25
Showing 25 citing articles:
Circadian Regulation of Drug Responses: Toward Sex-Specific and Personalized Chronotherapy
Françis Lévi, Alper Okyar, Éva Hadadi, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 89-114
Open Access | Times Cited: 31
Françis Lévi, Alper Okyar, Éva Hadadi, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 89-114
Open Access | Times Cited: 31
Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes: the Chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) study
Filippo Pigazzani, Kenneth A. Dyar, S. V. Morant, et al.
EClinicalMedicine (2024) Vol. 72, pp. 102633-102633
Open Access | Times Cited: 10
Filippo Pigazzani, Kenneth A. Dyar, S. V. Morant, et al.
EClinicalMedicine (2024) Vol. 72, pp. 102633-102633
Open Access | Times Cited: 10
Pioneering new frontiers in circadian medicine chronotherapies for cardiovascular health
Ifene David Festus, Jeri Spilberg, Martin E. Young, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 7, pp. 607-623
Open Access | Times Cited: 7
Ifene David Festus, Jeri Spilberg, Martin E. Young, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 7, pp. 607-623
Open Access | Times Cited: 7
Findings and Methodological Shortcomings of Investigations Concerning the Relationship Between Sleep Duration and Blood Pressure: A Comprehensive Narrative Review
Michael H. Smolensky, Ramón C. Hermida, Richard J. Castriotta, et al.
Journal of Cardiovascular Development and Disease (2025) Vol. 12, Iss. 3, pp. 95-95
Open Access
Michael H. Smolensky, Ramón C. Hermida, Richard J. Castriotta, et al.
Journal of Cardiovascular Development and Disease (2025) Vol. 12, Iss. 3, pp. 95-95
Open Access
Chronotherapy of hypertension: let's not throw the baby out with the bathwater!
Francesco P. Cappuccio, Roberto Manfredini, Filippo Pigazzani
Journal of Hypertension (2025) Vol. 43, Iss. 2, pp. 201-202
Open Access
Francesco P. Cappuccio, Roberto Manfredini, Filippo Pigazzani
Journal of Hypertension (2025) Vol. 43, Iss. 2, pp. 201-202
Open Access
Circadian chronotherapies of coronary heart disease and its biological risk factors: A United States Prescribers’ Digital Reference-based review
Sepideh Khoshnevis, Michael H. Smolensky, Ramón C. Hermida
Chronobiology International (2024) Vol. 41, Iss. 11, pp. 1365-1376
Closed Access | Times Cited: 2
Sepideh Khoshnevis, Michael H. Smolensky, Ramón C. Hermida
Chronobiology International (2024) Vol. 41, Iss. 11, pp. 1365-1376
Closed Access | Times Cited: 2
Circadian disruption and its impact on the cardiovascular system
Morag J. Young, Seamus Heanue, Monica Kanki, et al.
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 2
Morag J. Young, Seamus Heanue, Monica Kanki, et al.
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 2
Understanding the dosing-time-dependent antihypertensive effect of valsartan and aspirin through mathematical modeling
Javiera Cortés-Ríos, María Rodríguez-Fernández
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Javiera Cortés-Ríos, María Rodríguez-Fernández
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Systematic review and quality evaluation of published human ingestion-time trials of blood pressure-lowering medications and their combinations
Ramón C. Hermida, Ramon G. Hermida‐Ayala, Artemio Mojón, et al.
Chronobiology International (2021) Vol. 38, Iss. 10, pp. 1460-1476
Closed Access | Times Cited: 14
Ramón C. Hermida, Ramon G. Hermida‐Ayala, Artemio Mojón, et al.
Chronobiology International (2021) Vol. 38, Iss. 10, pp. 1460-1476
Closed Access | Times Cited: 14
The effect of bedtime versus morning dosing of antihypertensive drugs on the cardiovascular outcomes: a systematic review and meta-analysis of randomized controlled trials
Mohamed Abuelazm, Othman Saleh, Majd M. AlBarakat, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 10, pp. 1595-1605
Closed Access | Times Cited: 5
Mohamed Abuelazm, Othman Saleh, Majd M. AlBarakat, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 10, pp. 1595-1605
Closed Access | Times Cited: 5
Critical appraisal of recent translational chronopharmacology and chronotherapeutic reviews, meta-analyses, and pragmatic patient trials discloses significant deficiencies of design and conduct and suspect findings
Ramón C. Hermida, Michael H. Smolensky, Artemio Mojón, et al.
Chronobiology International (2023) Vol. 40, Iss. 8, pp. 1146-1167
Closed Access | Times Cited: 5
Ramón C. Hermida, Michael H. Smolensky, Artemio Mojón, et al.
Chronobiology International (2023) Vol. 40, Iss. 8, pp. 1146-1167
Closed Access | Times Cited: 5
Circadian rhythms of risk factors and management in atherosclerotic and hypertensive vascular disease: Modern chronobiological perspectives of an ancient disease
Yong‐Jian Geng, Michael H. Smolensky, Oliver Sum‐Ping, et al.
Chronobiology International (2022) Vol. 40, Iss. 1, pp. 33-62
Open Access | Times Cited: 8
Yong‐Jian Geng, Michael H. Smolensky, Oliver Sum‐Ping, et al.
Chronobiology International (2022) Vol. 40, Iss. 1, pp. 33-62
Open Access | Times Cited: 8
Clinical trial design for assessing hypertension medications: are critical circadian chronopharmacological principles being taking into account?
Ramón C. Hermida, Michael H. Smolensky, Artemio Mojón, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 119-130
Closed Access | Times Cited: 1
Ramón C. Hermida, Michael H. Smolensky, Artemio Mojón, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 119-130
Closed Access | Times Cited: 1
Lowering Nighttime Blood Pressure With Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension—Pro Side of the Argument
Ramón C. Hermida, Artemio Mojón, Michael H. Smolensky, et al.
Hypertension (2021) Vol. 78, Iss. 3, pp. 879-893
Open Access | Times Cited: 10
Ramón C. Hermida, Artemio Mojón, Michael H. Smolensky, et al.
Hypertension (2021) Vol. 78, Iss. 3, pp. 879-893
Open Access | Times Cited: 10
Ingestion-time differences in the pharmacodynamics of dual-combination hypertension therapies: Systematic review and meta-analysis of published human trials
Ramon G. Hermida‐Ayala, Artemio Mojón, José R. Fernández, et al.
Chronobiology International (2021) Vol. 39, Iss. 4, pp. 493-512
Closed Access | Times Cited: 9
Ramon G. Hermida‐Ayala, Artemio Mojón, José R. Fernández, et al.
Chronobiology International (2021) Vol. 39, Iss. 4, pp. 493-512
Closed Access | Times Cited: 9
Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature
Ramón C. Hermida, Artemio Mojón, José R. Fernández, et al.
Chronobiology International (2021) Vol. 40, Iss. 1, pp. 63-82
Closed Access | Times Cited: 8
Ramón C. Hermida, Artemio Mojón, José R. Fernández, et al.
Chronobiology International (2021) Vol. 40, Iss. 1, pp. 63-82
Closed Access | Times Cited: 8
Understanding Circadian Mechanisms of Sudden Cardiac Death: A Report From the National Heart, Lung, and Blood Institute Workshop, Part 2: Population and Clinical Considerations
Brian P. Delisle, Alfred L. George, Jeanne M. Nerbonne, et al.
Circulation Arrhythmia and Electrophysiology (2021) Vol. 14, Iss. 11
Open Access | Times Cited: 8
Brian P. Delisle, Alfred L. George, Jeanne M. Nerbonne, et al.
Circulation Arrhythmia and Electrophysiology (2021) Vol. 14, Iss. 11
Open Access | Times Cited: 8
Recommended timing of medications that impact sleep and wakefulness: A review of the American Prescribers’ Digital Reference
Sepideh Khoshnevis, Michael H. Smolensky, Shahab Haghayegh, et al.
Sleep Medicine Reviews (2022) Vol. 67, pp. 101714-101714
Closed Access | Times Cited: 5
Sepideh Khoshnevis, Michael H. Smolensky, Shahab Haghayegh, et al.
Sleep Medicine Reviews (2022) Vol. 67, pp. 101714-101714
Closed Access | Times Cited: 5
The Controversy of Chronotherapy: Emerging Evidence regarding Bedtime Dosing of Antihypertensive Medications in Non-Arteritic Anterior Ischemic Optic Neuropathy
Mary T. Labowsky, Joseph F. Rizzo
Seminars in Ophthalmology (2023) Vol. 38, Iss. 1, pp. 99-104
Closed Access | Times Cited: 2
Mary T. Labowsky, Joseph F. Rizzo
Seminars in Ophthalmology (2023) Vol. 38, Iss. 1, pp. 99-104
Closed Access | Times Cited: 2
Dosing time optimization of antihypertensive medications by including the circadian rhythm in pharmacokinetic-pharmacodynamic models
Javiera Cortés-Ríos, Ramón C. Hermida, María Rodríguez-Fernández
PLoS Computational Biology (2022) Vol. 18, Iss. 11, pp. e1010711-e1010711
Open Access | Times Cited: 3
Javiera Cortés-Ríos, Ramón C. Hermida, María Rodríguez-Fernández
PLoS Computational Biology (2022) Vol. 18, Iss. 11, pp. e1010711-e1010711
Open Access | Times Cited: 3
Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions
Yong‐Jian Geng, Rosalinda Madonna, Ramón C. Hermida, et al.
Current Research in Pharmacology and Drug Discovery (2021) Vol. 2, pp. 100025-100025
Open Access | Times Cited: 4
Yong‐Jian Geng, Rosalinda Madonna, Ramón C. Hermida, et al.
Current Research in Pharmacology and Drug Discovery (2021) Vol. 2, pp. 100025-100025
Open Access | Times Cited: 4
Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease
Chau Ho, Christopher M. Reid
Exploration of Medicine (2022) Vol. 2, Iss. 3, pp. 461-467
Open Access | Times Cited: 2
Chau Ho, Christopher M. Reid
Exploration of Medicine (2022) Vol. 2, Iss. 3, pp. 461-467
Open Access | Times Cited: 2
Commentary on Bowles and Shea: Further perspectives and clinical implications of ingestion-time differences in the efficacy of blood pressure-lowering medications
Michael H. Smolensky, Ramón C. Hermida
Sleep Medicine Reviews (2021) Vol. 59, pp. 101540-101540
Closed Access | Times Cited: 1
Michael H. Smolensky, Ramón C. Hermida
Sleep Medicine Reviews (2021) Vol. 59, pp. 101540-101540
Closed Access | Times Cited: 1
Insight on Cardiac Chronobiology and Latest Developments of Chronotherapeutic Antihypertensive Interventions for Better Clinical Outcomes
Kumud Joshi, Madhubanti Das, Anupam Sarma, et al.
Current Hypertension Reviews (2023) Vol. 19, Iss. 2, pp. 106-122
Closed Access
Kumud Joshi, Madhubanti Das, Anupam Sarma, et al.
Current Hypertension Reviews (2023) Vol. 19, Iss. 2, pp. 106-122
Closed Access
Does Patient‐Applied Testosterone Replacement Therapy Pose Risk for Blood Pressure Elevation? Circadian Medicine Perspectives
Michael H. Smolensky, Ramón C. Hermida, L Sackett-Lundeen, et al.
Comprehensive physiology (2022), pp. 4165-4184
Closed Access
Michael H. Smolensky, Ramón C. Hermida, L Sackett-Lundeen, et al.
Comprehensive physiology (2022), pp. 4165-4184
Closed Access
